Using the first-generation TSPO PET tracer (R)-[11C]PK11195, increased TSPO expression has been demonstrated in both MS lesions and normal appearing brain tissue of patients with MS, which was associated with increased disability and disease progression in all phases of the disease [11–16]. Here, TSPO is linked to myeloid sarcoma.